Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 10 Jun 2026 for Intellia Therapeutics, Inc..
Filing timeline
BuySaleJesse Goodman
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jesse Goodman: trading record in brief
Jesse Goodman discloses dealings in Intellia Therapeutics, Inc. to SEC (Form 4). Between 23 June 2021 and 9 June 2026, the trades on record add up to 8 filings.
No open-market purchase appears, only 2 sales worth €25k. The rest of the record consists of 6 share grants.
Most recently, on 10 June 2026, the filings show a share grant in Intellia Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jesse Goodman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
9,200 sharesCommon StockSEC:0001756929-26-000002:0
1,547 shares@ US$9.56100.0% of flowCommon StockSEC:0000950170-25-093302:0
8,000 shares0Common StockSEC:0000950170-25-086277:0
7,737 shares0Common StockSEC:0000950170-24-073700:0
4,425 shares0Common StockSEC:0001209191-23-037889:0
5,197 shares0Common StockSEC:0001209191-22-037600:0
2,094 shares0Common StockSEC:0001209191-21-043377:0
7 of 7 declarations
